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84 The Journal of Thoracic and Cardiobjective: We have established a low–priming volume cardiopulmonary bypass
ystem for pediatric heart surgery to avoid homologous blood transfusion. The
riming volume of our system is down to 140 mL for patients weighing less than 7 kg.
e can prime the bypass circuits without blood products for patients weighing more
han 4 kg.
ethods: Seventy consecutive patients weighing 4 to 7 kg underwent heart surgery
ith a bloodless prime from October 2003 to September 2006. The type of
rocedures (Risk Adjustment in Congenital Heart Surgery category) included the
ollowing: category 1: atrial septal defect (n  3); category 2: ventricular septal
efect, tetralogy of Fallot, bidirectional Glenn shunt, and others (n 55); category 3:
trioventricular septal defect, double-outlet right ventricle, and others (n  8);
ategory 4: Rastelli procedure for transposition of the great arteries (n  3); and
ategory 6, Damus–Kaye–Stansel procedure (n  1). Transfusion criteria were
ematocrit less than 20%, mixed venous oxygen saturation less than 70%, regional
erebral oxygenation less than 50%, and plasma lactate level greater than 4.0
mol/L during bypass.
esults: The mean age and body weight were 7.3  5.4 months and 5.4  0.8
g, respectively. Forty-five patients (64%) underwent transfusion-free proce-
ures. Preoperative hematocrit, age, body weight, complexity of procedure and
ardiopulmonary bypass time were compared between patients with and without
ransfusion. Bypass time and Risk Adjustment in Congenital Heart Surgery risk
ategory in patients with transfusion were significantly greater than those in
atients without (P  .0001, and P  .05, respectively). Body weight in patients
ithout transfusion was significantly greater than that in patients with (P  .01).
n multiple regression analysis, the determinants of blood transfusion were the
ypass time and body weight (odds ratio 1.026, 95% confidence interval 1.011–
040, P  .0001, and odds ratio 0.366, 95% confidence interval 0.171– 0.785,
 .01).
onclusions: It is possible to do complex transfusion-free procedures safely for
atients weighing more than 4 kg by using the low–priming volume circuit. The
imiting factors of bloodless heart surgery are not preoperative hematocrit and
omplexity of procedure but the cardiopulmonary bypass time and the patient’s
ody weight.
vascular Surgery ● August 2007
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Dn infants and children, anemia is one of the primary
problems observed during and after heart surgery. Be-
cause of the small circulating volume of blood, extreme
emodilution occurs when a large cardiopulmonary bypass
CPB) circuit is used. In that event, a homologous blood
ransfusion is required during CPB. However, a blood trans-
usion can potentially cause a variety of complications, such
s an immunologic reaction that causes organ dysfunction
nd infectious transmissions.1,2 To eliminate these risks, we
eveloped a low–priming volume CPB system for pediatric
eart surgery to avoid the need of a blood transfusion. The
riming volume of our system is as low as 140 mL. We can
rime the bypass circuits without blood products for pa-
ients weighing more than 4 kg and less than 7 kg. In this
rticle we retrospectively reviewed our experience with
loodless cardiac surgery for patients weighing between 4
nd 7 kg to determine the factors best predicting blood
ransfusion in the extremely low-priming CPB system.
atients and Methods
eventy consecutive patients weighing 4 to 7 kg underwent heart
urgery with a bloodless prime from October 2003 to September
006 in the Kitasato University Hospital. The mean age and body
eight were 7.3  5.4 months (range 1.6-28.6 months) and 5.4 
.8 kg (range 4.0-6.9 kg), respectively. There were 29 boys and 41
irls. The type of procedures and the Risk Adjustment in Congen-
tal Heart Surgery (RACHS) risk category3,4 are shown in Table 1.
here were 60 patients with biventricular repair and 10 with
niventricular repair (bidirectional Glenn shunt, 8; Damus–Kaye–
tansel anastomosis, 1; and aortoplasty, 1).
Criteria for red blood cell transfusion included anemia with a
ematocrit level of less than 20% during CPB for patients who had
ndergone biventricular repair and less than 25% during CPB for
hose who had undergone univentricular repair. After modified
ltrafiltration (MUF), the autologous transfusion was performed to
eep the hematocrit level of 25% for patients with biventricular
epair and 35% of those with univentricular repair.
We monitored mixed venous oxygen saturation (SvO2) and
egional cerebral oxygenation (rSO2) using near-infrared spectros-
opy (INVOS 5100; Somanetics, Inc, Troy, Mich) during CPB and
aintained the values above 70% and 50%, respectively. If we had
ifficulty maintaining the SvO2 above 70% and rSO2 above 50%,
espite increasing the pump flow or oxygen concentration during
PB, we decided to transfuse the allogeneic blood. The plasma
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
MUF modified ultrafiltration
RACHS Risk Adjustment in Congenital Heart
Surgery
rSO2  regional cerebral oxygenation
SvO2 mixed venous oxygen saturationactate level (micromoles per liter) was also monitored during C
The Journal of Thoracicypass, and when the lactate increased above 4.0 mmol/L, we
ecided to transfuse the allogeneic blood. If postoperative hemo-
ynamic instability persisted despite sufficient inotropic support,
e decided to transfuse red blood cells even when the hematocrit
evel was above 25%. We did not transfuse platelets or fresh frozen
lasma before red blood cell transfusion in the present study.
rythropoietin was not used preoperatively or postoperatively.
he Miniaturized CPB System
o achieve a low–priming volume CPB system, we needed a
ow-prime oxygenator and reservoir (priming volume, 40 mL;
aby RX; Terumo Inc, Tokyo, Japan), arterial filters (15 mL;
iltia; JMS Inc, Hiroshima, Japan), and a smaller and shortened
xtracorporeal circuit. The oxygenator, reservoir, and circuits were
oated with biocompatible poly 2-methoxyethylacrylate. To
horten the circuit, we placed the CPB roller pump close enough to
he operative field to minimize tubing length. Our CPB system
onsisted of a distant roller-pump head, a remote-controlled
nit, and a sterilized sheet. The distant roller pump and remote-
ontrolled unit (TONOKURA Compo III; Tonokura Medical Inc,
okyo, Japan) allows maximal proximity to the operative field
Figure 1). The sterilized sheet (50  100 mm, SteriSheet; Tono-
ura Medical Inc, Tokyo, Japan), made of polyvinyl chloride, acts
s a protective barrier between the first assistant and the CPB unit
Figure 2). The arterial, venous, and suction tubes are attached to
he sheet and then covered by an unwoven, polypropylene sheet.
he tubes were 3/16 inch in diameter at the pump heads, and the
est of the tubes were 5/32 inch in diameter. With this system, the
otal length of the circuit was reduced to about 280 cm, and its
riming volume was reduced to 65 mL. The minimum priming
olume of this system is currently 140 mL with 15 mL of the
eservoir level. Albumin or any other colloid was not used in the
ABLE 1. Type of procedures and RACHS risk category
ACHS risk category Procedure No. of patients
ategory 1 ASD closure 3
ategory 2 VSD closure 32
TOF repair 10
BCPS 8
RVOTR 3
MVR/MVP 2
ategory 3 AVSD repair 4
DORV repair 2
TOF/PA repair 1
Aortoplasty 1
ategory 4 Rastelli operation 3
ategory 6 DKS 1
otal 70
ACHS, Risk Adjustment in Congenital Heart Surgery; ASD, atrial septal
efect; VSD, ventricular septal defect; TOF, tetralogy of Fallot; BCPC,
idirectional cavopulmonary shunt; RVOTR, right ventricular outflow tract
econstruction; MVR, mitral valve replacement; MVP, mitral valvuloplasty;
VSD, atrioventricular septal defect; DORV, double-outlet right ventricle;
A, pulmonary atresia; DKS, Damus–Kaye–Stansel procedure.PB prime.
and Cardiovascular Surgery ● Volume 134, Number 2 285
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DPB Techniques
lood gas management was performed with the pH-stat strategy. A
igh-flow (150 mL · kg1 · min1) normal to mildly hypothermic
32°C) CPB was used. Crystalloid cardioplegic solution (10 mL/kg)
as given every 20 minutes. After termination of the bypass, MUF
as performed with a polymethylmethacrylate hemofilter in all
atients. MUF was started with an ultrafiltration rate of 5 to
0 mL · kg1 · min1 for 5 to 10 minutes. The heparinization was
eutralized by protamine sulfate until the activated coagulation
ime had normalized. A cell salvage device was used during the
rocedure, and the remaining blood in the CPB circuit was re-
urned to the patient within the operative day. Aprotinin was not
sed in the present study.
tudy Protocol
ata collected from all the patients included age, sex, body weight,
ypes of procedure, resternotomy, CPB time, the lowest SvO2,
igure 2. Arrangement of the operating room and the sterilized
olyvinyl chloride sheet is close to the first assistant’s right
lbow and functions as a protective barrier between the patient
nd the unsterilized CPB unit. The arterial, venous, and suction1ircuits are attached to the sheet.
86 The Journal of Thoracic and Cardiovascular Surgery ● AuguSO2, and highest plasma lactate level during CPB, preoperative
ematocrit levels, the lowest hematocrit levels during CPB, the
ematocrit level, the dose of the inotropic agent (dopamine) that
as used at the separation from CPB, and usage and volume of
lood product transfused. Data collection was performed accord-
ng to the guidelines of the institutional review board. Seventy
atients were divided into two groups: the transfusion group
group 1) and the nontransfusion group (group 2). Age, sex, body
eight, the RACHS risk category, resternotomy, CPB time, and
reoperative hematocrit levels were analyzed as risk factors for
lood transfusion in both groups. Multiple logistic regression
nalysis was used to determine the factors that best predicted the
lood transfusion using a low–priming volume CPB system.
tatistical Analysis
ifferences in patient characteristics between the transfusion
roup and the nontransfusion group were examined by Mann–
hitney–Wilcoxon tests and rank sum tests for continuous vari-
bles and by the Fisher exact tests for dichotomous variables. Then
he bivariate relationships among these variables were examined
y calculating the Spearman rank correlation coefficients for con-
inuous variables. Multiple logistic regression analysis was used to
nvestigate which of the factors best predicted the need for a blood
ransfusion. All of the factors were entered and removed at a
ignificance level of P  .05 by either forward multiple logistic or
ackward stepwise regression analysis. Sex, resternotomy, and
ACHS risk category were modeled with binary dummy variables,
hereas body weight, age, preoperative hematocrit, and perfusion
ime were examined as continuous variables.
esults
PB was begun with crystalloid (bloodless) prime in all
atients. There was 1 operative death. A patient with a double-
utlet of the right ventricle and a Taussig–Bing anomaly,
ho underwent a Rastelli operation, died of pulmonary
ypertension crisis. This patient received an intraoperative
ransfusion.
The mean follow-up period was 621 days (range 86–
Figure 1. System of low-priming extra-
corporeal circulation (Tonokura Com-
ponent System III). The distant roller
pump and remote-controlled unit al-
lows maximal proximity to the opera-
tive field.283 days), and no postoperative neurologic deficits, in-
st 2007
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Dluding seizure activity, delirium or delusion, or significant
otor dysfunction, were found by the cardiologists or the
arents. All patients are being followed up by pediatric
ardiologists at our outpatient clinic. No mortalities or neu-
ologic sequelae have been reported. As a part of follow-up,
he Japanese infant developmental scale (Enjoji Scale of
nfant Analytical Development)5 was used for patients with-
ut mental retardation diagnosed before surgery (4 patients)
r chromosomal abnormality (14 patients). Pediatric cardi-
logists at our outpatient clinic performed the tests when the
atients were from 1 to 3 years old. There were no neuro-
evelopmental deficits in these patients.
The lowest hematocrit level was 22.2%  3.5% (range
5.7%-30.4%), and the hematocrit level at separation from
PB was 24.0%  4.6% (range 19.8%-35.4%). The lowest
vO2 and rSO2 were 71.9%  5.3% (range 56%-84%) and
3.4%  8.6% (range 27%-70%), respectively. The highest
lasma lactate level during CPB was 2.3  1.2 mmol/L
range 0.9-9.2 mmol/L). The dose of dopamine required for
eaning from CPB was 4.2  1.9 g · mL1 · kg1 (range
-10 g · mL1 · kg1). All the patients were separated
rom CPB easily without any other inotropic agents, such as
pinephrine or norepinephrine. In patients with univentricu-
ar repair, the hematocrit level at separation from CPB was
7.7%  2.3% (range 23.7%-30.7%), and the dose of do-
amine required for weaning from CPB was 4.7  2.7 g ·
L1 · kg1 (range 0-10 g · mL1 · kg1). There were no
ignificant differences in the dose of inotropic agents be-
ween patients with biventricular repair and univentricular
ABLE 2. Clinical characteristics and surgical data
Group 1
(n  25)
Group 2
(n  45)
Difference
(P values)
ge (mo) 6.5 5.2 7.7  5.4 .362
ex (male/female) 15/10 26/19 .364
ody weight (kg) 5.0 0.8 5.6  0.8 .006
reoperative Hct (%) 37.1 8.2 38.7 5.8 .349
esternotomy 10/15 9/36 .071
ACHS risk category 2.6 1.0 2.1  0.5 .006
PB time (min) 141.2 46.2 92.5 41.4 .0001
notropic agent (dopamine:
g · mL1 · kg1)
5.1  1.7 3.8  1.8 .004
ct (%) at separation from
CPB
28.1 3.0 21.8 3.6 .0001
owest Hct (%) 22.9 3.4 21.7 3.5 .14
owest SvO2 (%) 71.4 7.8 72.2 3.3 .51
owest rSO2 (%) 52.7 10.4 53.8 7.5 .639
ighest plasma lactate
(mmol/L)
2.8  1.8 2.1  0.5 .012
ct, Hematocrit; RACHS, Risk Adjustment in Congenital Heart Surgery;
PB, cardiopulmonary bypass; SvO2, mixed venous oxygen saturation; rSO2,
egional cerebral oxygenation. An inotropic agent was needed for sepa-
ation from CPB.epair (4.2 1.7 vs 4.7 2.7g · mL1 · kg1; P .40). There T
The Journal of Thoracicere no correlations between the hematocrit level and the
ose of dopamine at separation from CPB (Pearson corre-
ation coefficient  0.20; P  .10).
Twenty-five of 70 (35.7%) patients received a trans-
usion during their operation or stay in the intensive care
nit. Of the 25 patients who received a transfusion, 21
atients required blood to maintain hematocrit level,
vO2, rSO2 or plasma lactate level during CPB and 4
atients required blood because of hemodynamic insta-
ility after the termination of CPB. The fresh frozen
lasma was transfused in 2 patients, and platelets were
ransfused in 5 patients after red blood cell transfusion.
he clinical characteristics and surgical data in the pa-
ients with transfusion (group 1) and without transfusion
group 2) are shown in Table 2. Significant differences
ere observed in body weight, RACHS risk category,
PB time, hematocrit level and dose of inotropic agents
t separation from CPB, and highest plasma lactate level
P  0.006, P  0.027, P  0.0001, P  0.0001, P 
.004, and P  0.006, respectively).
We used multiple logistic regression analysis to discover
he explanatory variable that could best predict the need for
blood transfusion (Table 3). Our results reveal that a
ombination of CPB time and body weight best predicts the
eed for a blood transfusion: odds ratios 1.026 (95% con-
dence interval, 1.019-1.033) (P  .0001) and 0.366 (95%
onfidence interval, 0.224-0.508) (P  0.01). Age, sex,
esternotomy, RACHS risk category, and preoperative he-
atocrit were not selected as significant predictors of the
eed for a blood transfusion.
iscussion
large amount of blood products is needed in cardiac
urgery for neonates and small infants to avoid hemodilu-
ion. Efforts have been made to minimize the unnecessary
se of homologous blood in the pediatric population.6-8 The
iniaturized CPB system may allow transfusion-free heart
urgery for small infants and children9 and sometimes for
eonates.10 In our institution, we have developed a priming
olume CPB system with the minimal volume of 140 mL
or patients weighing more than 4 and less than 7 kg. Using
his system, we can prime the CPB circuit without blood
roducts for patients weighing more than 4 kg but less than
kg. Of 70 patients weighing between 4 and 7 kg, 45 (64%)
atients underwent heart surgery without blood transfusion.
ABLE 3. Clinical characteristics and surgical data
elected variables Odds ratios (95% CI) P values
PB time (min) 1.026 (1.019-1.033) .0001
ody weight (kg) 0.366 (0.224-0.508) .010
I, Confidence interval; CPB, cardiopulmonary bypass.his patient group included complex procedures, such as
and Cardiovascular Surgery ● Volume 134, Number 2 287
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Detralogy of Fallot repair, atrioventricular septal defect re-
air, and the Rastelli operation.
One of the most potentially limiting factors to bloodless
eart surgery is the patient’s preoperative hematocrit level.
eduction of the priming volume can reduce this limiting
actor. The present study revealed that the CPB time and the
atient’s body weight best predicted the need for a blood
ransfusion, instead of the patient’s age, procedure complex-
ty, resternotomy, and preoperative hematocrit value in the
iniaturized CPB circuit. The miniaturized CPB circuit
lso reduces the surface contact of the circulating blood
nd, thus, is expected to reduce the overall inflammatory
esponses.11-13
Many investigators6,9,10 reported that low-hematocrit by-
ass was effective in avoiding the need for allogeneic trans-
usion. Kurth and associates14 also reported that the lowest
afe hematocrit level was approximately 15%. Croughwell
nd colleagues15 reported that there was a marked increase
n cognitive impairment when jugular venous oxygen satu-
ation was less than 50%. Therefore, to prevent neurologic
equelae, our transfusion criteria during bypass were hemat-
crit less than 20%, SvO2 less than 70%, rSO2 less than 50%,
nd plasma lactate level greater than 4.0 mmol/L. On the
ther hand, recent reports have addressed concern for ad-
erse effects of hemodilution during CPB on neurologic
utcome. Jonas and coworkers16 reported, in a study includ-
ng newborns, those who required profound hypothermia
nd/or circulatory arrest, that the use of a lower hematocrit
evel during CPB (22%) resulted in lower psychomotor
evelopment than did the use of a higher hematocrit. Ando
nd coworkers9 reported that no neurologic sequelae were
een and psychomotor development appeared normal despite
he low hematocrit level (approximately 15%) observed
uring CPB. In their study, the infant psychomotor scale
ssessment questionnaire was used to assess overall mental
nd motor developments of the individual compared with
hat of the normal population. This assessment is considered
eliable and valid in the age range of between 1 and 3 years.
owever, the patient group investigated included only acya-
otic patients with a simple heart lesion—ventricular septal
efect.
Several investigators reported the importance and use-
ulness of cerebral monitoring during cardiac surgery,17-19
specially during low-hematocrit bypass.20 In the present
tudy, SvO2, hematocrit values, and rSO2 were continuously
onitored during CPB. In all patients, we monitored rSO2
sing near-infrared spectroscopy, in which two probes were
laced on the forehead bilaterally. With this system,
hanges in intracranial oxygenation were recorded every
econd during the operation. The rSO2 was used as an
ndicator of trends in cerebral oxygenation.21
The most important parameter during CPB is organ ox-
gen delivery, not hematocrit level, SvO2, and rSO2. There-
88 The Journal of Thoracic and Cardiovascular Surgery ● Auguore, we monitored plasma lactate level every 30 minutes
uring and after bypass for all patients. The highest lactate
evel in patients with transfusion was significantly greater
han that in patients without (P  .05), although there were
o significant differences in hematocrit level, SvO2, and
SO2, between two groups. These results supported that the
lasma lactate level is one of the most sensitive indexes of
ital organ oxygen delivery.22,23
More inotropic agent was needed for separation from
PB in patients with a transfusion than in those without one
P  .01), even though the hematocrit level at separation
rom CPB in the transfused group was significantly greater
han that in the bloodless heart surgery group, because the
ransfused group underwent more complicated procedures
nd required a longer CPB time. There was no tendency that
ore inotropes were required in patients with lower hemat-
crit levels in our study.
In summary, of 70 patients weighing between 4 and 7 kg,
5 (64%) patients underwent transfusion-free procedures.
ith the low–priming volume circuit, it is possible to do
omplex transfusion-free procedures safely for patients
eighing more than 4 kg and less than 7 kg. The limiting
actors of bloodless heart surgery are not preoperative he-
atocrit or complexity of procedure, but CPB time and
ody weight, despite using a miniaturized bypass system.
urther investigation and follow-up studies are warranted to
etermine a safe, low-hematocrit strategy in transfusion-
ree procedures for uneventful neurologic development.
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